Differential chromatin accessibility response to retinoic acid in neuroblastoma with ATRX in-frame-deletions versus ATRX loss-of-function.
- DOI
- 10.1016/j.neo.2025.101263
- Published
- 2026 Feb
- Container
- Neoplasia (New York, N.Y.)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.neo.2025.101263,
title = {Differential chromatin accessibility response to retinoic acid in neuroblastoma with ATRX in-frame-deletions versus ATRX loss-of-function.},
author = {Lorenzi F and Shipley M and Deane L and Goldstone R and Tandon V and da Costa BM and Greenslade K and Barker K and Nemati F and Bellini A and Schleiermacher G and Chesler L and Guillemot F and George SL},
year = {2026},
journal = {Neoplasia (New York, N.Y.)},
doi = {10.1016/j.neo.2025.101263},
url = {https://doi.org/10.1016/j.neo.2025.101263}
}RIS
TY - JOUR TI - Differential chromatin accessibility response to retinoic acid in neuroblastoma with ATRX in-frame-deletions versus ATRX loss-of-function. AU - Lorenzi F AU - Shipley M AU - Deane L AU - Goldstone R AU - Tandon V AU - da Costa BM AU - Greenslade K AU - Barker K AU - Nemati F AU - Bellini A AU - Schleiermacher G AU - Chesler L AU - Guillemot F AU - George SL PY - 2026 JO - Neoplasia (New York, N.Y.) DO - 10.1016/j.neo.2025.101263 UR - https://doi.org/10.1016/j.neo.2025.101263 ER -
APA
F, L., M, S., L, D., R, G., V, T., BM, D. C., K, G., K, B., F, N., A, B., G, S., L, C., F, G., & SL, G. (2026). Differential chromatin accessibility response to retinoic acid in neuroblastoma with ATRX in-frame-deletions versus ATRX loss-of-function.. Neoplasia (New York, N.Y.). https://doi.org/10.1016/j.neo.2025.101263